by HAEMATO AG | Aug 31, 2017 | Investor News
HAEMATO AG is a listed pharmaceutical company focusing on the growth markets of patent-free and patent-protected drugs primarily in the high-price indicative areas of oncology and HIV as well as in the areas of rheumatism, neurology and cardiac, circulatory diseases....
